These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 31434797)

  • 41. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
    Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
    Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.
    Xiao H; Zeng J; Li H; Chen K; Yu G; Hu J; Tang K; Zhou H; Huang Q; Li A; Li Y; Ye Z; Wang J; Xu H
    Oncotarget; 2015 May; 6(15):13201-15. PubMed ID: 26036633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31767633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ceRNA PVT1 inhibits proliferation of ccRCC cells by sponging miR-328-3p to elevate FAM193B expression.
    Xie G; Zheng X; Zheng Z; Wu R; Yao Z; Huang W; Sun F; Mu X; Wu K; Zheng J
    Aging (Albany NY); 2021 Sep; 13(17):21712-21728. PubMed ID: 34518442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma.
    Wang X; Chen X; Han W; Ruan A; Chen L; Wang R; Xu Z; Xiao P; Lu X; Zhao Y; Zhou J; Chen S; Du Q; Yang H; Zhang X
    Mol Cancer Res; 2015 Dec; 13(12):1567-77. PubMed ID: 26248649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin.
    Jingushi K; Kashiwagi Y; Ueda Y; Kitae K; Hase H; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
    Int J Oncol; 2017 Jul; 51(1):289-297. PubMed ID: 28534944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
    Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C
    Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.
    Hong Y; Huang X; An L; Ye H; Ma K; Zhang F; Xu Q
    Exp Cell Res; 2018 Apr; 365(2):163-170. PubMed ID: 29477618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC).
    Pesta M; Travnicek I; Kulda V; Ostasov P; Windrichova J; Houfkova K; Knizkova T; Bendova B; Hes O; Hora M; Topolcan O; Polivka J
    In Vivo; 2024; 38(4):1799-1805. PubMed ID: 38936941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
    Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
    EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CircAKT1 acts as a sponge of miR-338-3p to facilitate clear cell renal cell carcinoma progression by up-regulating CAV1.
    Zhu Q; Zhan D; Zhu P; Chong Y; Yang Y
    Biochem Biophys Res Commun; 2020 Nov; 532(4):584-590. PubMed ID: 32900491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma.
    Lv Q; Wang G; Zhang Y; Shen A; Tang J; Sun Y; Ma C; Wang P
    J Exp Clin Cancer Res; 2021 Feb; 40(1):76. PubMed ID: 33618745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma.
    Zhao H; Zhao H; Xia X; Liu X
    Mol Med Rep; 2018 May; 17(5):7451-7459. PubMed ID: 29568870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.